Parkinson Clinical Trials

11 recruiting

Frequently Asked Questions

Common questions about Parkinson clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 642 trials

Recruiting
Not Applicable

Vestibular and Cortical Contributions to Transitions in Freezing of Gait in Parkinson's Disease

Parkinson Disease
University of Minnesota75 enrolled1 locationNCT06506058
Recruiting

PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort

Parkinson Disease
Michael J. Fox Foundation for Parkinson's Research4,500 enrolled50 locationsNCT04477785
Recruiting
Phase 2

Safety, Tolerability and Symptomatic Efficacy of the ROCK-Inhibitor Fasudil in Patients With Parkinson's Disease

Idiopathic Parkinson´s Disease
Technical University of Munich75 enrolled1 locationNCT05931575
Recruiting
Not Applicable

Cerebellar Stimulation and Cognitive Control

DepressionParkinson DiseaseSchizophrenia+2 more
Krystal Parker, PhD200 enrolled1 locationNCT03217110
Recruiting
Phase 2Phase 3

A Study of Buntanetap in Participants With PD

Deep Brain StimulationParkinson's Disease (PD)
Annovis Bio Inc.500 enrolled26 locationsNCT07284784
Recruiting
Not Applicable

Characterizing the Pathophysiological Role of the Pallido-thalamocortical Motor Pathway in Parkinson's Disease.

Parkinson Disease
University of Minnesota25 enrolled1 locationNCT06692920
Recruiting
Phase 1

[18F]F-DOPA Imaging in Patients With Autonomic Failure

Multiple System AtrophyParkinson DiseaseDementia With Lewy Bodies+2 more
Daniel Claassen40 enrolled1 locationNCT04246437
Recruiting
Not Applicable

Cue2Walk, Cost-effectiveness of Automated Freezing Detection and Provision of External Cues in Comparison to Usual Care in People With Parkinson's Disease

Parkinson Disease
Amsterdam UMC, location VUmc84 enrolled2 locationsNCT06416345
Recruiting
Phase 2Phase 3

Montelukast in Parkinson Disease

Parkinson Disease
Mostafa Bahaa60 enrolled1 locationNCT06113640
Recruiting
Not Applicable

Rehabilitation With Dual-task Exercises to Improve Balance in Patients With Parkinson's Disease

Parkinson Disease (PD), Postural Balance
G. d'Annunzio University74 enrolled1 locationNCT07013214
Recruiting
Phase 3

Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease

PARKINSON DISEASE (Disorder)
University Hospital Tuebingen150 enrolled3 locationsNCT07151378
Recruiting

Radiofrequency (RF) Ablation Prospective Outcomes Study for Central Nervous System - RAPID for CNS

Movement DisordersParkinson DiseaseDystonia+1 more
Boston Scientific Corporation200 enrolled4 locationsNCT06553625
Recruiting
Phase 1

This Clinical Trial is Designed to Evaluate the Safety, Tolerability, Feasibility and Preliminary Efficacy of NouvNeu001 (Human Dopaminergic Progenitor Cells Injection) in Patients With Parkinson's Disease.

Parkinson Disease
iRegene Therapeutics Co., Ltd.5 enrolled1 locationNCT07102342
Recruiting
Not Applicable

Exergaming for Imrpving Upper Limb Functions in Parkinson's Disease

Parkinsons Disease (PD)
University of Health Sciences Lahore30 enrolled1 locationNCT07475741
Recruiting
Not Applicable

Exercise to Improve Sleep in Parkinson's Disease

Parkinson Disease
McGill University150 enrolled3 locationsNCT05644327
Recruiting

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Parkinson's Disease
Boston Scientific Corporation1,500 enrolled84 locationsNCT02071134
Recruiting
Not Applicable

Spinal Cord Stimulation for Parkinson's Disease Rehabilitation

Parkinson Disease
University of Louisville20 enrolled1 locationNCT06804642
Recruiting
Not Applicable

Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease (ADAPT-PD) China Study

Parkinson's Disease
MedtronicNeuro62 enrolled5 locationsNCT07216976
Recruiting

Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disease and Alzheimer's Disease.

Diabete Type 2PARKINSON DISEASE (Disorder)Alzheimer s Disease
Neuromed IRCCS500 enrolled1 locationNCT07467460
Recruiting

A Study to Assess Change in Sleep Disturbances of Adult Participants With Advanced Parkinson's Disease Receiving Subcutaneous Foslevodopa/Foscarbidopa

Advanced Parkinson's Disease
AbbVie103 enrolled13 locationsNCT07284342